Copyright Reports & Markets. All rights reserved.

Global Influenza Drugs Market Insights and Forecast to 2026

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Influenza Drugs Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Influenza Drugs Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Influenza Drugs Market Size Growth Rate by Type
    • 1.4.2 Zanamivir
    • 1.4.3 Oseltamivir Phosphate
    • 1.4.4 Peramivir
    • 1.4.5 Other Influenza Drugs
  • 1.5 Market by Application
    • 1.5.1 Global Influenza Drugs Market Size Growth Rate by Application
    • 1.5.2 Adults
    • 1.5.3 Chidren
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global Influenza Drugs Market Size, Estimates and Forecasts
    • 2.1.1 Global Influenza Drugs Revenue 2015-2026
    • 2.1.2 Global Influenza Drugs Sales 2015-2026
  • 2.2 Global Influenza Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
    • 2.2.1 Global Influenza Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Influenza Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Influenza Drugs Competitor Landscape by Players

  • 3.1 Influenza Drugs Sales by Manufacturers
    • 3.1.1 Influenza Drugs Sales by Manufacturers (2015-2020)
    • 3.1.2 Influenza Drugs Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Influenza Drugs Revenue by Manufacturers
    • 3.2.1 Influenza Drugs Revenue by Manufacturers (2015-2020)
    • 3.2.2 Influenza Drugs Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Influenza Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Influenza Drugs Revenue in 2019
    • 3.2.5 Global Influenza Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Influenza Drugs Price by Manufacturers
  • 3.4 Influenza Drugs Manufacturing Base Distribution, Product Types
    • 3.4.1 Influenza Drugs Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Influenza Drugs Product Type
    • 3.4.3 Date of International Manufacturers Enter into Influenza Drugs Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Influenza Drugs Market Size by Type (2015-2020)
    • 4.1.1 Global Influenza Drugs Sales by Type (2015-2020)
    • 4.1.2 Global Influenza Drugs Revenue by Type (2015-2020)
    • 4.1.3 Influenza Drugs Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Influenza Drugs Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Influenza Drugs Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Influenza Drugs Revenue Forecast by Type (2021-2026)
    • 4.2.3 Influenza Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Influenza Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

  • 5.1 Global Influenza Drugs Market Size by Application (2015-2020)
    • 5.1.1 Global Influenza Drugs Sales by Application (2015-2020)
    • 5.1.2 Global Influenza Drugs Revenue by Application (2015-2020)
    • 5.1.3 Influenza Drugs Price by Application (2015-2020)
  • 5.2 Influenza Drugs Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Influenza Drugs Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Influenza Drugs Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Influenza Drugs Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America Influenza Drugs by Country
    • 6.1.1 North America Influenza Drugs Sales by Country
    • 6.1.2 North America Influenza Drugs Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America Influenza Drugs Market Facts & Figures by Type
  • 6.3 North America Influenza Drugs Market Facts & Figures by Application

7 Europe

  • 7.1 Europe Influenza Drugs by Country
    • 7.1.1 Europe Influenza Drugs Sales by Country
    • 7.1.2 Europe Influenza Drugs Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Influenza Drugs Market Facts & Figures by Type
  • 7.3 Europe Influenza Drugs Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific Influenza Drugs by Region
    • 8.1.1 Asia Pacific Influenza Drugs Sales by Region
    • 8.1.2 Asia Pacific Influenza Drugs Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific Influenza Drugs Market Facts & Figures by Type
  • 8.3 Asia Pacific Influenza Drugs Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America Influenza Drugs by Country
    • 9.1.1 Latin America Influenza Drugs Sales by Country
    • 9.1.2 Latin America Influenza Drugs Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America Influenza Drugs Market Facts & Figures by Type
  • 9.3 Central & South America Influenza Drugs Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa Influenza Drugs by Country
    • 10.1.1 Middle East and Africa Influenza Drugs Sales by Country
    • 10.1.2 Middle East and Africa Influenza Drugs Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa Influenza Drugs Market Facts & Figures by Type
  • 10.3 Middle East and Africa Influenza Drugs Market Facts & Figures by Application

11 Company Profiles

  • 11.1 Bristol-Myers Squibb]
    • 11.1.1 Bristol-Myers Squibb] Corporation Information
    • 11.1.2 Bristol-Myers Squibb] Description and Business Overview
    • 11.1.3 Bristol-Myers Squibb] Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Bristol-Myers Squibb] Influenza Drugs Products Offered
    • 11.1.5 Bristol-Myers Squibb] Related Developments
  • 11.2 AstraZeneca
    • 11.2.1 AstraZeneca Corporation Information
    • 11.2.2 AstraZeneca Description and Business Overview
    • 11.2.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 AstraZeneca Influenza Drugs Products Offered
    • 11.2.5 AstraZeneca Related Developments
  • 11.3 Eli Lilly
    • 11.3.1 Eli Lilly Corporation Information
    • 11.3.2 Eli Lilly Description and Business Overview
    • 11.3.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 Eli Lilly Influenza Drugs Products Offered
    • 11.3.5 Eli Lilly Related Developments
  • 11.4 Roche
    • 11.4.1 Roche Corporation Information
    • 11.4.2 Roche Description and Business Overview
    • 11.4.3 Roche Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 Roche Influenza Drugs Products Offered
    • 11.4.5 Roche Related Developments
  • 11.5 GlaxoSmithKline
    • 11.5.1 GlaxoSmithKline Corporation Information
    • 11.5.2 GlaxoSmithKline Description and Business Overview
    • 11.5.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 GlaxoSmithKline Influenza Drugs Products Offered
    • 11.5.5 GlaxoSmithKline Related Developments
  • 11.6 Novartis
    • 11.6.1 Novartis Corporation Information
    • 11.6.2 Novartis Description and Business Overview
    • 11.6.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 Novartis Influenza Drugs Products Offered
    • 11.6.5 Novartis Related Developments
  • 11.7 Pfizer
    • 11.7.1 Pfizer Corporation Information
    • 11.7.2 Pfizer Description and Business Overview
    • 11.7.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
    • 11.7.4 Pfizer Influenza Drugs Products Offered
    • 11.7.5 Pfizer Related Developments
  • 11.8 Sanofi Pasteur
    • 11.8.1 Sanofi Pasteur Corporation Information
    • 11.8.2 Sanofi Pasteur Description and Business Overview
    • 11.8.3 Sanofi Pasteur Sales, Revenue and Gross Margin (2015-2020)
    • 11.8.4 Sanofi Pasteur Influenza Drugs Products Offered
    • 11.8.5 Sanofi Pasteur Related Developments
  • 11.9 Bayer
    • 11.9.1 Bayer Corporation Information
    • 11.9.2 Bayer Description and Business Overview
    • 11.9.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
    • 11.9.4 Bayer Influenza Drugs Products Offered
    • 11.9.5 Bayer Related Developments
  • 11.10 Celgene
    • 11.10.1 Celgene Corporation Information
    • 11.10.2 Celgene Description and Business Overview
    • 11.10.3 Celgene Sales, Revenue and Gross Margin (2015-2020)
    • 11.10.4 Celgene Influenza Drugs Products Offered
    • 11.10.5 Celgene Related Developments
  • 11.1 Bristol-Myers Squibb]
    • 11.1.1 Bristol-Myers Squibb] Corporation Information
    • 11.1.2 Bristol-Myers Squibb] Description and Business Overview
    • 11.1.3 Bristol-Myers Squibb] Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Bristol-Myers Squibb] Influenza Drugs Products Offered
    • 11.1.5 Bristol-Myers Squibb] Related Developments
  • 11.12 Protein Sciences Corporation
    • 11.12.1 Protein Sciences Corporation Corporation Information
    • 11.12.2 Protein Sciences Corporation Description and Business Overview
    • 11.12.3 Protein Sciences Corporation Sales, Revenue and Gross Margin (2015-2020)
    • 11.12.4 Protein Sciences Corporation Products Offered
    • 11.12.5 Protein Sciences Corporation Related Developments
  • 11.13 Serum Institute of India
    • 11.13.1 Serum Institute of India Corporation Information
    • 11.13.2 Serum Institute of India Description and Business Overview
    • 11.13.3 Serum Institute of India Sales, Revenue and Gross Margin (2015-2020)
    • 11.13.4 Serum Institute of India Products Offered
    • 11.13.5 Serum Institute of India Related Developments
  • 11.14 Emergent Biosolutions
    • 11.14.1 Emergent Biosolutions Corporation Information
    • 11.14.2 Emergent Biosolutions Description and Business Overview
    • 11.14.3 Emergent Biosolutions Sales, Revenue and Gross Margin (2015-2020)
    • 11.14.4 Emergent Biosolutions Products Offered
    • 11.14.5 Emergent Biosolutions Related Developments
  • 11.15 BioCryst Pharmaceuticals
    • 11.15.1 BioCryst Pharmaceuticals Corporation Information
    • 11.15.2 BioCryst Pharmaceuticals Description and Business Overview
    • 11.15.3 BioCryst Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
    • 11.15.4 BioCryst Pharmaceuticals Products Offered
    • 11.15.5 BioCryst Pharmaceuticals Related Developments
  • 11.16 Alvogen
    • 11.16.1 Alvogen Corporation Information
    • 11.16.2 Alvogen Description and Business Overview
    • 11.16.3 Alvogen Sales, Revenue and Gross Margin (2015-2020)
    • 11.16.4 Alvogen Products Offered
    • 11.16.5 Alvogen Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Influenza Drugs Market Estimates and Projections by Region
    • 12.1.1 Global Influenza Drugs Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Influenza Drugs Revenue Forecast by Regions 2021-2026
  • 12.2 North America Influenza Drugs Market Size Forecast (2021-2026)
    • 12.2.1 North America: Influenza Drugs Sales Forecast (2021-2026)
    • 12.2.2 North America: Influenza Drugs Revenue Forecast (2021-2026)
    • 12.2.3 North America: Influenza Drugs Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Influenza Drugs Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Influenza Drugs Sales Forecast (2021-2026)
    • 12.3.2 Europe: Influenza Drugs Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Influenza Drugs Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Influenza Drugs Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Influenza Drugs Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Influenza Drugs Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Influenza Drugs Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Influenza Drugs Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Influenza Drugs Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Influenza Drugs Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Influenza Drugs Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Influenza Drugs Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Influenza Drugs Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Influenza Drugs Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Influenza Drugs Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter's Five Forces Analysis
  • 13.5 Primary Interviews with Key Influenza Drugs Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Influenza Drugs Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source
    • 16.2 Author Details

    Influenza Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Influenza Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

    Segment by Type, the Influenza Drugs market is segmented into
    Zanamivir
    Oseltamivir Phosphate
    Peramivir
    Other Influenza Drugs

    Segment by Application, the Influenza Drugs market is segmented into
    Adults
    Chidren

    Regional and Country-level Analysis
    The Influenza Drugs market is analysed and market size information is provided by regions (countries).
    The key regions covered in the Influenza Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
    Competitive Landscape and Influenza Drugs Market Share Analysis
    Influenza Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Influenza Drugs business, the date to enter into the Influenza Drugs market, Influenza Drugs product introduction, recent developments, etc.

    The major vendors covered:
    Bristol-Myers Squibb]
    AstraZeneca
    Eli Lilly
    Roche
    GlaxoSmithKline
    Novartis
    Pfizer
    Sanofi Pasteur
    Bayer
    Celgene
    Seqirus
    Protein Sciences Corporation
    Serum Institute of India
    Emergent Biosolutions
    BioCryst Pharmaceuticals
    Alvogen

    Buy now